Scarica l'app Stockscreener
6.69
1.04%
-0.07
Dopo l'orario di chiusura:
6.60
-0.09
-1.35%
Engene Holdings Inc Borsa (ENGN) Ultime notizie
Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail
enGene Holdings Inc (ENGN) Income Statement - TradingKey
Market Leaders: What analysts say about enGene Holdings Inc Equity Warrant stockDollar Strength & High Accuracy Trade Alerts - baoquankhu1.vn
ENGNW SEC FilingsForbion European Acquisition Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Tangible book value per share of enGene Holdings Inc. – NASDAQ:ENGNW - TradingView
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 25.3% in March - MarketBeat
Bull Run: Why is enGene Holdings Inc Equity Warrant stock going upQuarterly Profit Summary & Daily Entry Point Alerts - baoquankhu1.vn
Setup Watch: What are the analyst revisions for enGene Holdings IncIs FACT stock a good investment in YEARInflation Watch & Community Consensus Trade Alerts - baoquankhu1.vn
Energy Moves: Is enGene Holdings Inc Equity Warrant impacted by rising ratesMarket Sentiment Review & Precise Trade Entry Recommendations - baoquankhu1.vn
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sentiment Watch: Is enGene Holdings Inc Equity Warrant stock a value trapPortfolio Update Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Boston Scientific (BSX) - The Globe and Mail
UBS cuts Engene Holdings stock price target on trial costs - Investing.com UK
UBS cuts Engene Holdings stock price target on trial costs By Investing.com - Investing.com South Africa
Volume Recap: Can enGene Holdings Inc Equity Warrant lead its sector in growth2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
Bank Watch: Is enGene Holdings Inc a stock for growth or value investors2026 Short Interest & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Sell Signal: How does enGene Holdings Inc compare to its peersQuarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Valuation Update: What analysts say about enGene Holdings Inc Equity Warrant stock2026 Snapshot & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Bank Watch: Is enGene Holdings Inc Equity Warrants ROE strong enough2026 Sector Review & Verified Momentum Stock Alerts - baoquankhu1.vn
ENGN PE Ratio & Valuation, Is ENGN Overvalued - Intellectia AI
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care - The Globe and Mail
enGene CEO Pitches Detalimogene as Community-Friendly NMIBC Option, Teases Q2 LEGEND Data Update - MarketBeat
enGene Shares Detalimogene NMIBC Trial Changes, FDA Endpoint Shift, and 2027 Approval Path at Conference - MarketBeat
Portfolio Update: Is enGene Holdings Inc stock a good dividend stock2026 Performance Recap & Community Trade Idea Sharing Platform - baoquankhu1.vn
Aug Reactions: Why is enGene Holdings Inc Equity Warrant stock going up2026 EndofYear Setup & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Short Interest in enGene Holdings Inc. (NASDAQ:ENGN) Decreases By 17.7% - MarketBeat
enGene Highlights 2026 Data Catalysts, BLA Plans for Bladder Cancer Gene Therapy at Barclays Conference - MarketBeat
Braidwell LP Invests $15.48 Million in enGene Holdings Inc. $ENGN - MarketBeat
enGene (NASDAQ:ENGN) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Oppenheimer Issues Pessimistic Forecast for enGene (NASDAQ:ENGN) Stock Price - Defense World
Merger Talk: Can enGene Holdings Inc Equity Warrant lead its sector in growth2026 Key Highlights & Reliable Price Action Trade Plans - baoquankhu1.vn
AI Stocks: Will enGene Holdings Inc stock benefit from M A2026 Short Interest & Entry and Exit Point Strategies - baoquankhu1.vn
enGene Holdings: Key Catalysts Incoming For 2026 (NASDAQ:ENGN) - Seeking Alpha
enGene (NASDAQ:ENGN) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Citizens reiterates Engene Holdings stock rating on BLA timeline By Investing.com - Investing.com South Africa
HC Wainwright Has Optimistic Outlook of enGene Q2 Earnings - MarketBeat
Citizens reiterates Engene Holdings stock rating on BLA timeline - Investing.com
FY2030 Earnings Forecast for enGene Issued By HC Wainwright - Defense World
enGene Shares Gain 5% After Bladder Cancer Therapy Shows Stronger Response Rates - MSN
enGene (NASDAQ:ENGN) Price Target Lowered to $30.00 at Oppenheimer - MarketBeat
Pullback Watch: How does enGene Holdings Inc compare to its peers2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn
ENGN: Detalimogene offers promising efficacy and convenience for NMIBC, with pivotal data updates ahead - TradingView
HC Wainwright Has Positive Outlook of enGene FY2030 Earnings - MarketBeat
enGene Holdings (ENGN) Gets a Buy from Wells Fargo - The Globe and Mail
Smart Money: Can SIFCO Industries Inc continue delivering strong returns2026 Momentum & Stepwise Trade Signal Guides - baoquankhu1.vn
ENGN: Detalimogene's pivotal data and unique profile position it to transform NMIBC treatment - TradingView
enGene (NASDAQ:ENGN) Posts Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
ENGN: Detalimogene offers a unique, highly tolerable NMIBC therapy with pivotal data updates in 2024 - TradingView
Engene stock price target lowered to $27 by Guggenheim on estimates - za.investing.com
enGene Reports Q1 2026 Results, Advances Detalimogene for Bladder Cancer with Strong Cash Position and FDA Milestones 12 - minichart.com.sg
Raymond James Maintains Strong Buy on ENGN enGene Holdings Inc March 2026 - Meyka
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):